Science now describes the resolution of inflammation as an active biological process with its own control machinery, not a passive shutdown. A January 2026 Nature Communications paper described a molecular family that directs monocyte fate in that process. PEMF has not been tested against that mechanism, and there is no basis for claiming it "switches it on." A Chinese medicine practitioner examines what is known — and what is not.
August 2026 · 11 min read · Guest Article
Inflammation is one of the body's most important defence mechanisms. When tissue is damaged, or the immune system detects a threat, the body mounts a complex response intended to protect, clear damage and begin repair.
For many years the scientific focus was largely on how inflammation begins and how to reduce it once it becomes excessive or prolonged. Modern research presents a more complex picture: normal inflammation is not only an activation process but a timed system that includes active control mechanisms enabling its termination and a gradual return to balance.
This research field is called Resolution of Inflammation, and it describes the processes by which the body moves from an active immune response to a phase of recovery and repair [1]. What is striking is that ending inflammation is not a passive "switching off" but an active biological process with its own regulatory pathways.
After an immune response is triggered, the body does not simply extinguish it. Active control mechanisms steer the immune system from a defensive state toward resolution and recovery.
One published study examined the role of molecules from the epoxy-oxylipin family, derived from fatty-acid pathways [2]. The researchers looked at how these molecules affect monocytes — immune cells with a significant role in the inflammatory response. The findings indicate that these molecules are involved in regulating immune-cell activity during the transition toward resolution and recovery.
An important precision: this is not a single "switch" that turns off all inflammation in the body, but a complex system of control mechanisms acting together. That complexity is exactly what changes how science views inflammation — not merely as a process to suppress, but as a staged process that includes the body's own capacity to end it.
Acute inflammation is essential. But when inflammatory processes remain active over time, they may participate in complex systems linked to various chronic conditions.
Many studies point to associations between chronic inflammation and a range of medical conditions, among them cardiovascular disease, metabolic disorders and processes related to ageing [3]. This does not mean every chronic condition arises from inflammation alone, but that the body's ability to regulate inflammatory responses is one of the important components in understanding health and disease.
These discoveries raise an interesting question: if cells possess natural control mechanisms enabling a transition from an inflammatory state to recovery, can gentle external stimuli support that capacity?
This is where the research question around biophysical technologies such as PEMF — Pulsed Electromagnetic Fields enters. PEMF is based on generating pulses of an electromagnetic field, studied in various rehabilitation contexts including bone healing, pain, tissue repair and the regulation of cellular responses [4]. Unlike a treatment based on a chemical agent, this is a physical stimulus intended to influence biological processes through intercellular communication and cell signalling pathways.
But an interesting research question does follow: might biophysical technologies support the cell's own capacity to activate and regulate its balance mechanisms? That remains an open question for research.
Various studies have examined the possible effects of PEMF on biological systems. Among the areas studied:
For example, a laboratory study examined the effect of PEMF on IL-6 — a molecule involved in inflammatory processes — in intervertebral disc cells, and on the NF-κB and p38 MAPK signalling pathways associated with regulating an inflammatory response [5].
These studies are interesting because they suggest that a physical stimulus can influence how cells communicate and respond to their environment. Nonetheless, further research is needed into how these findings translate into clinical effect in humans — a study in cells in a laboratory is not evidence of an outcome in a patient.
One of the things I find most compelling as a practitioner is watching modern science approach questions that have long sat at the centre of Chinese medicine's way of looking at the body. This is not to say that science and Chinese medicine describe the same mechanisms, but that both direct attention to balance, adaptation, and a system's ability to return to optimal function.
Chinese medicine treats health as a state of dynamic balance between the body's systems, working from the premise that the body has a natural capacity to reorganise itself toward health. From my perspective as a practitioner, the meeting between new scientific research and this systemic view does not replace science — it opens new possibilities for observation and for asking questions.
One of the interesting directions in future medicine is the move from focusing solely on identifying disease and suppressing symptoms toward a deeper understanding of the body's own control and recovery mechanisms. The new research on resolution reminds us that the body is not merely a system that reacts to damage, but a complex system with capacities for regulation, adaptation and repair.
It remains too early to say that PEMF directly affects the resolution mechanisms identified in the new research, and work in the field continues. But the possibility of examining the relationship between physical signals, cellular processes and the body's natural regulatory mechanisms opens interesting directions for further study.
Giora Mor, Dip. Ac. I.A.TCM
A licensed Chinese medicine practitioner since 1997 and director of "Mor Integrated Clinic". Extensive experience in acupuncture; integrates biophysical technologies as part of a systemic therapeutic approach, and studies the meeting point between clinical experience, scientific research and the body's natural capacity for balance.
This article presents research and scientific developments in the fields of inflammation-resolution mechanisms and biophysical technologies. The information presented does not claim that PEMF has been proven to activate the resolution mechanisms identified in the epoxy-oxylipin studies. Its purpose is to present the scientific developments, the existing PEMF research, and the future questions arising from the meeting of cell biology, technology and the body's natural capacity for balance.
From here on — by the PainFree editorial team. The section below was written by PainFree and is not part of Giora Mor's article.
No. Not one study has tested PEMF against the epoxy-oxylipin mechanism described in Nature Communications in 2026. These are two separate bodies of research that have not yet met. Any claim connecting them is speculation, not a finding.
The existing evidence is largely laboratory-based (in vitro): reduced IL-6 expression in intervertebral disc cells via the NF-κB and p38 MAPK pathways (Spine 2019, PubMed 31689248), and a review of effects on inflammation regulation and tissue regeneration (Bioelectricity 2019, PubMed 34471827). A finding in cells is not a clinical outcome.
No. PEMF replaces the need for other passive pain-reduction modalities (such as TENS currents or analgesics), but it does not replace manual therapy and active exercise — it works in combination with them. No medication prescribed by a physician should be stopped without that physician's instruction.
PEMF is a non-invasive treatment in which a magnetic coil is applied over the treatment area. It is not painful, requires no undressing, and involves no sensation of electrical currents or pricking — the patient simply lies or sits comfortably while the device operates. A typical session is about 30 minutes, and treatment cost in the Philippines is ₱1,500–₱2,500 per session.
No — and this is one of the most important distinctions. Devices differ substantially in field intensity, frequencies, coil size and built-in protocols. There are three separate categories that should not be confused: a clinical PEMF system operated in clinic after diagnosis; a medical-grade home device, more powerful than common consumer home devices and less powerful than the clinical system, which can be used daily and even twice daily while reading or watching television; and consumer wellness products such as mats, which are not medical equipment and carry no defined indication.
Warning signs require a physician, not a complementary clinic: high fever with local swelling and redness, pain that wakes the patient from sleep and worsens at rest, unexplained weight loss, progressive weakness or loss of sensation, or signs of infection. Inflammation is not always "an overactive system" — sometimes it is the first sign of a condition requiring diagnosis.
70+ Israeli clinics serving a population of 9M — now expanding to the Philippines. Treatment is delivered hands-free and does not require continuous direct supervision, so revenue is generated while the practitioner treats another patient in a parallel room: it does not compete with the manual-therapy fee but is added to it. Each system ships with clinical staff training, an indication-specific protocol book, and ongoing technical and clinical support.
Hebrew original: painfree.org.il. This page is informational and is not medical advice; it does not replace diagnosis, treatment or follow-up by a treating physician.
Interested in adding PEMF to your clinic? Request the full investment brief — machine specs, financials, and site selection for the Philippines market.
Request Investment Brief →